Costs and effects of combining stenting and abciximab (ReoPro ®) in daily practice
Publication date
2001
Authors
Zwart - van Rijkom, J.E.F.
Klungel, Olaf H.
Leufkens, H.G.
Broekmans, A.W.
Schrijver-van Velthoven, S
Umans, V.A
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
Zwart - van Rijkom, J E F, Klungel, O H, Leufkens, H G M, Broekmans, A W, Schrijver-van Velthoven, S & Umans, V A 2001, 'Costs and effects of combining stenting and abciximab (ReoPro ®) in daily practice', International Journal of Cardiology, vol. 77, pp. 299-303.